(Q43829243)

27 November 2017

title

Prediction of hemorrhagic transformation in acute ischaemic stroke by micro- and macroalbuminuria after intravenous thrombolysis (English)

1 reference

27 November 2017

1 reference

B-H Cho

1

1 reference

27 November 2017

J-T Kim

2

1 reference

27 November 2017

J Chang

3

1 reference

27 November 2017

K-H Choi

4

1 reference

27 November 2017

M-S Park

5

1 reference

27 November 2017

K-H Cho

6

1 reference

27 November 2017

publication date

14 April 2013

1 reference

European Journal of Neurology

27 November 2017

published in

1 reference

27 November 2017

volume

20

1 reference

27 November 2017

issue

8

1 reference

27 November 2017

page(s)

1145-1152

1 reference

Tissue plasminogen activator for acute ischemic stroke

27 November 2017

cites work

1 reference

Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?

21 January 2018

1 reference

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

21 January 2018

1 reference

Reperfusion after severe local perfusion deficit precedes hemorrhagic transformation: an MRI study in acute stroke patients.

21 January 2018

1 reference

Brain hemorrhage after thrombolysis: good or bad?

21 January 2018

1 reference

Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry

21 January 2018

1 reference

Is asymptomatic hemorrhagic transformation really innocuous?

21 January 2018

1 reference

Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion

21 January 2018

1 reference

Early fibrinogen degradation coagulopathy is predictive of parenchymal hematomas in cerebral rt-PA thrombolysis: a study of 157 cases

21 January 2018

1 reference

Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke

21 January 2018

1 reference

Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes

21 January 2018

1 reference

What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?

21 January 2018

1 reference

Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment?

21 January 2018

1 reference

Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke.

21 January 2018

1 reference

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

21 January 2018

1 reference

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

21 January 2018

1 reference

Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model

21 January 2018

1 reference

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

21 January 2018

1 reference

Urinary albumin:creatinine ratio (ACR) and the prediction of postoperative complications after abdominal aortic aneurysm repair

21 January 2018

1 reference

Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock

21 January 2018

1 reference

Microalbuminuria in ischemic stroke

21 January 2018

1 reference

Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study.

21 January 2018

1 reference

Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects.

21 January 2018

1 reference

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

21 January 2018

1 reference

Regression of microalbuminuria in type 1 diabetes

21 January 2018

1 reference

Albumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permeability and ischemic brain injury in rats

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ENE.12127

1 reference

27 November 2017

1 reference